Argonaute-2

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
NitisinoneSC-0735; SYN-118; NTBCApprovedSwedish Orphan Biovitrum AgOrfadin, NityrUnited StatesTyrosinemiasSwedish Orphan Biovitrum Ag2002-01-18Alkaptonuria; Blindness; Tyrosinemias; Albinism
Details
  • Product Inquiry
  • Marketed Drug Information